150 related articles for article (PubMed ID: 6184732)
1. Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome.
Grant SJ; Redmond DE
Pharmacol Biochem Behav; 1982 Oct; 17(4):655-8. PubMed ID: 6184732
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine.
Kleven MS; Sparber SB
Pharmacol Biochem Behav; 1987 Oct; 28(2):235-41. PubMed ID: 2446338
[TBL] [Abstract][Full Text] [Related]
3. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
Collier HO; Cuthbert NJ; Francis DL
Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
[TBL] [Abstract][Full Text] [Related]
4. Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Kleven MS; Sparber SB
Psychopharmacology (Berl); 1989; 98(2):231-5. PubMed ID: 2474176
[TBL] [Abstract][Full Text] [Related]
5. Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain.
Galloway MP; Roth RH
J Neurochem; 1983 Jan; 40(1):246-51. PubMed ID: 6184449
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat.
Shearman GT; Lal H; Ursillo RC
Pharmacol Biochem Behav; 1980 Apr; 12(4):573-5. PubMed ID: 7190295
[TBL] [Abstract][Full Text] [Related]
7. The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective.
Neal BS; Sparber SB
Psychopharmacology (Berl); 1990; 100(2):258-66. PubMed ID: 1689501
[TBL] [Abstract][Full Text] [Related]
8. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
Kleven MS; Sparber SB
J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats.
Buccafusco JJ; Marshall DC; Turner RM
Life Sci; 1984 Sep; 35(13):1401-8. PubMed ID: 6148677
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of neonatal exposure to isobutylmethylxanthine. II. Attenuation of acute morphine withdrawal in mature rats.
Neal BS; Messing RB; Sparber SB
Psychopharmacology (Berl); 1991; 103(3):398-406. PubMed ID: 1711704
[TBL] [Abstract][Full Text] [Related]
11. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
[TBL] [Abstract][Full Text] [Related]
12. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
Zaluzny SG; Chesher GB; Jackson DM; Malor R
Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.
Cervo L; Rochat C; Romandini S; Samanin R
Psychopharmacology (Berl); 1981; 74(3):271-4. PubMed ID: 6791237
[TBL] [Abstract][Full Text] [Related]
14. Blocking naloxone-precipitated withdrawal in rats and hamsters.
Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
[TBL] [Abstract][Full Text] [Related]
15. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
[TBL] [Abstract][Full Text] [Related]
16. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.
Britton KT; Svensson T; Schwartz J; Bloom FE; Koob GF
Life Sci; 1984 Jan; 34(2):133-9. PubMed ID: 6537983
[TBL] [Abstract][Full Text] [Related]
17. Myoelectric activity of the small intestine during morphine dependence and withdrawal in rats.
Kuperman DA; Sninsky CA; Lynch DF
Am J Physiol; 1987 Apr; 252(4 Pt 1):G562-7. PubMed ID: 3565571
[TBL] [Abstract][Full Text] [Related]
18. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.
Dwoskin LP; Neal BS; Sparber SB
Eur J Pharmacol; 1983 Jun; 90(2-3):269-73. PubMed ID: 6683657
[TBL] [Abstract][Full Text] [Related]
19. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine.
Rada P; Pothos E; Mark GP; Hoebel BG
Brain Res; 1991 Oct; 561(2):354-6. PubMed ID: 1802350
[TBL] [Abstract][Full Text] [Related]
20. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.
Silverstone PH; Done C; Sharp T
Psychopharmacology (Berl); 1992; 109(1-2):235-8. PubMed ID: 1365663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
